Currently browsing Amphora News

New Company Plans to Market Microbicide by 2010
Tuesday, August 1st, 2006

Tommy Thompson Chairs Instead Sciences

LA JOLLA, Calif. – Local women’s health company Instead Inc. and Tommy Thompson have formed a new company called Instead Sciences, Inc. to complete the final stage of clinical trials, product development and market launch of its promising microbicide Amphora(TM) (clinically known as Acidform).
“Amphora–which already has FDA safety clearance for […]


Amphora™ Selected by CDC for Microbicide Clinical Trial in Madagascar
Thursday, December 1st, 2005

Amphora™ Selected for Microbicide Clinical Trial
Madagascar Formative Study to Evaluate
Amphora’s Acceptability among High-risk Women
La Jolla, CA (December 1, 2005) – Amphora™ (clinically known as Acidform) was selected by the U.S. Centers for Disease Control and Prevention (CDC), the United States Agency for International Development (USAID), the Contraceptive Research and Development (CONRAD), and the University […]


Instead, Inc. Secures Approval to Launch Disposable Diaphragm in Russia
Wednesday, July 23rd, 2003

Russian Academy of Medical Sciences will prioritize clinical tests of Instead® Softcup® and Amphora® for pregnancy and STD prevention
San Diego, CA – Instead, Inc., today announced it has received approval from the Russian Academy of Medical Sciences to market its Instead® Softcup® as an over-the-counter disposable contraceptive diaphragm in the Russian Federation beginning immediately.